CDG Invest PME (CIP), a Morocco-based private equity firm previously known as CDG Capital Private Equity, and Techniques Science-Santé (T2S), IM Alliance, Cyclopharma and Binarios (together, the company or the group) have announced the signing of an agreement for the sale of a majority stake in the largest and most diversified group of medtech companies in Morocco to funds managed by Helios Investment Partners.